Skip to content
Trial Eligibility
Menu

The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty

NCT06991231

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this study is to evaluate the efficacy of cryoablation use on patient-reported outcomes (PROMs) and opioid consumption following total knee arthroplasty. This is a randomized study that will involve a 1:1 randomization to total knee arthroplasty +/- cryoablation.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Post-Operative Pain
  • Total Knee Arthroplasty

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
NYU Langone Health
Last updated on ClinicalTrials.gov
April 3, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • NYU Langone Health · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.